XERS FY 2020 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+650.7% YoY

Gross Profit

$11M54.4% margin

Operating Income

-$84M-408.8% margin

Net Income

-$91M-446.0% margin

EPS (Diluted)

$-2.14

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$97M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$159M

Total Liabilities

$125M

Stockholders' Equity

$34M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$3M	+650.7%
Gross Profit	$11M	$1M	+892.6%
Operating Income	-$84M	-$122M	+31.7%
Net Income	-$91M	-$126M	+27.4%